Josh Wolfe

Josh Wolfe
Name	Josh Wolfe
Birth date	1970s
Nationality	American
Occupation	Venture capitalist, investor, author
Known for	Co-founder of Lux Capital

Josh Wolfe is an American venture capitalist and co-founder of Lux Capital, a firm focused on emerging technologies in deep tech, robotics, space, biotechnology, and advanced materials. He is known for investments in companies working on nanotechnology, synthetic biology, space systems, and photonics, and for writing and commentary on technology policy and innovation ecosystems. Wolfe frequently appears in media and at conferences discussing future technologies, scientific entrepreneurship, and national competitiveness.

Early life and education

Wolfe studied in institutions that emphasize science and technology. He earned degrees at universities associated with science policy and international affairs, where he engaged with programs connected to science research, entrepreneurship, and technology transfer at venues such as Harvard University, Massachusetts Institute of Technology, Columbia University, and other institutions involved in the study of innovation. During this period he interacted with researchers from laboratories like Lawrence Livermore National Laboratory, Bell Labs, and university spinout ecosystems tied to hospitals and research centers.

Career

Wolfe co-founded Lux Capital, building a portfolio that bridges academic research and commercial ventures, often collaborating with principal investigators from institutions such as Stanford University, California Institute of Technology, University of California, Berkeley, and MIT. He has participated in policy discussions involving agencies and entities including NASA, Defense Advanced Research Projects Agency, National Institutes of Health, and industrial partners like DARPA contractors and national laboratories. Wolfe has engaged with accelerators and incubators connected to Y Combinator, Plug and Play Tech Center, and university technology transfer offices, advising on intellectual property and commercialization pathways. He has also served as an advisor or board observer for startups and non-profits working at the intersection of science and capital markets, interfacing with stakeholders in Silicon Valley, New York City, Boston, and international tech hubs like Tel Aviv and London.

Investments and notable companies

Through Lux Capital, Wolfe backed companies across sectors including aerospace, semiconductors, synthetic biology, and imaging. Notable investments and portfolio companies include ventures working on small satellite systems akin to those from Planet Labs, launch firms resembling SpaceX and Relativity Space, optics and imaging companies comparable to Lytro and Nokia acquisitions, photonics startups similar to NVIDIA-adjacent firms, and synthetic biology firms in the mold of Ginkgo Bioworks and Zymergen. He has supported entrepreneurs developing autonomous systems and robotics in the tradition of companies like Boston Dynamics and industrial automation firms tied to ABB and Siemens. Wolfe’s portfolio also contains firms addressing materials science and nanotechnology with parallels to breakthroughs from IBM Research, 3M, and academic spinouts from MIT Media Lab and Harvard Wyss Institute.

Writings and media appearances

Wolfe is a frequent commentator in outlets covering technology and science policy, appearing on platforms such as The New York Times, The Wall Street Journal, Forbes, Wired, Bloomberg, and on broadcast media including CNBC, NPR, and BBC News. He authors essays and opinion pieces that reference issues linked to agencies and works like DARPA programs, fiscal and industrial policy debates in the United States Senate, and reports from organizations such as the National Science Foundation and World Economic Forum. Wolfe has participated in conferences hosted by TED, SXSW, TechCrunch Disrupt, World Economic Forum Annual Meeting, and symposia at institutions like Aspen Institute and Council on Foreign Relations on topics such as space commercialization, artificial intelligence, and biotechnology governance.

Awards and recognition

Wolfe has been recognized by industry and media organizations for his influence in venture capital and science investing. His firm and he have been featured in lists and rankings produced by publications such as Fortune, Forbes, Bloomberg Businessweek, and trade organizations associated with venture capital and startup ecosystems like the National Venture Capital Association. He has received invitations to speak at award ceremonies and academic convocations at universities including Harvard, Stanford, and Caltech, and has been profiled in business histories and analyses of deep tech investing.

Personal life and philanthropy

Wolfe is active in philanthropic and civic efforts tied to science, technology, and education, supporting initiatives connected to foundations and institutions such as the Bill & Melinda Gates Foundation-style philanthropic models, university endowments, and non-profits focused on STEM outreach like FIRST and museum institutions similar to the Smithsonian Institution and science centers. He participates in advisory boards for research institutes, contributes to scholarship funds and innovation prizes, and engages with conservation and public policy NGOs operating in areas such as global health and space policy, including entities like AAAS and The Rockefeller Foundation.

Category:American venture capitalists Category:Living people